background
Bloodstream Infection Tests
Clinical Impact After Laboratory Implementation of the Verigene Gram-Negative Bacteria Microarray For Positive Blood Cultures
Utilization of a DNA Hybridization-Based, Rapid Molecular Diagnostic Test for Faster Bacterial Identification and Antimicrobial Optimization in Bacteremic Patients
Outcomes Utilizing Pharmacist Intervention and Rapid Molecular Diagnostic Technology (RMDT) in Patients with Gram-Positive Bloodstream Infections (BSI)
Impact of Integrating the Nanosphere Verigene Gram-Positive Blood Culture (BC-GP) Test with Antimicrobial Stewardship in a Non-Teaching Community Hospital
Potential Impact of a Microarray-Based Nucleic Acid Assay for the Rapid Detection of Gram-Negative Bacteria and Resistance Markers in Positive Blood Cultures
Rapid Detection of Gram-Negative Bacteria and Resistance Determinants Directly from Positive Blood Cultures Using the Microarray-Based Sample-to-Result Verigene® BC-GN Assay
Accuracy and Potential Clinical Utility of Two Rapid Molecular Panels for Detection of Bloodstream Infection
Multi-Centre Evaluation of Verigene® BC-GN Test for Rapid Detection of Gram-Negative Bacteria from Positive Blood Cultures from Pediatric Inpatients
Impact of the Verigene® Gram-Positive Blood Culture Assay in a Tertiary Care Pediatric Hospital
Pages
